Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Probl Tuberk ; (2): 14-7, 2001.
Artigo em Russo | MEDLINE | ID: mdl-11490456

RESUMO

The efficiency of various preventive treatment regimens was studied in 330 new cases of childhood tuberculosis by using clinical and laboratory findings and follow-up data. The paper shows it expedient to conduct a comprehensive immunological studies by tuberculin diagnosis and to examine immunity both at the time of infection detection in children and at their follow-ups. Monotherapy by the routine regimen can be performed in low tuberculin-sensitive children without risk factors. Children who have a complex of risk factors need long-term preventive treatment with two tuberculosis controlling agents. When immune responsiveness declines in children, it is necessary to apply pathogenetic agents that possess an immunomodulating effect, which substantially raise the efficiency of preventive treatment.


Assuntos
Tuberculose Pulmonar/prevenção & controle , Adjuvantes Imunológicos/uso terapêutico , Adolescente , Fatores Etários , Antituberculosos/administração & dosagem , Antituberculosos/uso terapêutico , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Masculino , Fatores de Risco , Fatores Sexuais , Fatores de Tempo , Teste Tuberculínico , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/imunologia
2.
Probl Tuberk ; (2): 8-11, 2001.
Artigo em Russo | MEDLINE | ID: mdl-11490482

RESUMO

Ample clinical material obtained in Yakutia was used to study the efficiency of combined treatment in patients with disseminated pulmonary tuberculosis concurrent with gastrointestinal and respiratory diseases. At the same time it was justifiable to employ alternatives to deliver antituberculous agents to the lesion focus (rectal dropwise administration, phono- and photophoresis of isoniazid, endobronchial colloid diluted rifampicin, and activated silver water diluted antituberculous drugs) with additional biophysical exposure. This made this group of patients have much better antituberculous agent intolerance, which increased nonbacterial isolation rates and closed decay cavities as compared with conventional methods for administering antituberculous agents.


Assuntos
Antituberculosos/uso terapêutico , Tuberculose Pulmonar/tratamento farmacológico , Animais , Antibióticos Antituberculose/administração & dosagem , Antibióticos Antituberculose/uso terapêutico , Antituberculosos/administração & dosagem , Gastroenteropatias/complicações , Humanos , Isoniazida/administração & dosagem , Isoniazida/uso terapêutico , Fonoforese , Coelhos , Doenças Respiratórias/complicações , Rifampina/administração & dosagem , Rifampina/uso terapêutico , Fatores de Tempo , Tuberculose Pulmonar/complicações
3.
Probl Tuberk ; (2): 17-8, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9235572

RESUMO

A new endobronchial treatment has been developed for patients with destructive pulmonary tuberculosis with massive bacterial excretion, complicated by chronic nonspecific endobronchitis. The treatment includes inhalation therapy with antituberculous drugs dissolved in activated silver water. This treatment of 42 patients has shown more than 2-fold increases in the rate of massive bacterial excretion cessation.


Assuntos
Antituberculosos/uso terapêutico , Isoniazida/uso terapêutico , Mycobacterium tuberculosis/isolamento & purificação , Escarro/microbiologia , Tuberculose Pulmonar/tratamento farmacológico , Administração por Inalação , Antituberculosos/administração & dosagem , Humanos , Isoniazida/administração & dosagem , Resultado do Tratamento , Tuberculose Pulmonar/microbiologia
4.
Probl Tuberk ; (2): 21-2, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9235575

RESUMO

A procedure has been developed for the use of semiconductor laser radiation in the combined drug therapy of patients with disseminated infiltrative pulmonary tuberculosis with multiple destructions and massive bacterial excretion, by increasing the number of sessions, which reduces the time of bacterial excretion cessation by 2-4 weeks, decay cavity closure by a months, and hospital treatment by 1.5 months and promotes minimal residual changes in most of them.


Assuntos
Terapia a Laser , Tuberculose Pulmonar/radioterapia , Adulto , Idoso , Antituberculosos/uso terapêutico , Seguimentos , Humanos , Pessoa de Meia-Idade , Radioterapia Adjuvante , Resultado do Tratamento , Tuberculose Pulmonar/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...